Howard Hughes Medical Institute’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-140
Closed -$12.4K 412
2025
Q4
$12.4K Hold
140
0.01% 178
2025
Q3
$12.6K Buy
140
+4
+3% +$324 0.01% 175
2025
Q2
$10.3K Buy
+136
New +$10.1K ﹤0.01% 198

Other funds holding SRE

Howard Hughes Medical Institute's SRE Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Sempra (SRE) in Q1 2026, closing a stake of 140 shares — an estimated $12.4K sold.

Howard Hughes Medical Institute first reported a position in SRE in Q2 2025 and held it in 3 quarters. The position peaked at $12.6K in Q3 2025. 1,266 funds tracked by Wall St. Rank hold SRE as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Sempra position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 140 Sempra shares in Q1 2026, an estimated $12.4K.
  • Howard Hughes Medical Institute first reported a position in Sempra in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Sempra position peaked at $12.6K in Q3 2025.
  • 1,266 funds tracked by Wall St. Rank held Sempra as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.